يعرض 1 - 10 نتائج من 28 نتيجة بحث عن '"Merola, Joseph"', وقت الاستعلام: 1.02s تنقيح النتائج
  1. 1
    مؤتمر
    P165 Kinetics of mucocutaneous and musculoskeletal responses to deucravacitinib in patients with systemic lupus erythematosus (SLE) in the phase 2 PAISLEY trial

    المؤلفون: Vollenhoven, Ronald F van, Merola, Joseph F, Dao, Kathryn H, Leszczynski, Piotr, Pike, Marilyn, Pomponi, Samantha, Hobar, Coburn, Colombo, Matthew J, Koti, Ravi, Banerjee, Subhashis, Wegman, Thomas, Morand, Eric

    المصدر: Poster Presentations

    الإتاحة: https://doi.org/10.1136/lupus-2024-el.219Test

    View record in BASE

    أضف إلى المفضلة
  2. 2
    مؤتمر
    P45 Specialists’ comfort with cutaneous lupus erythematosus reveals potential gaps and a need for co-management strategies

    المؤلفون: Rex, Ryan, May, Sawyer, Merola, Joseph F

    المصدر: Poster Presentations

    الإتاحة: https://doi.org/10.1136/lupus-2024-el.99Test

    View record in BASE

    أضف إلى المفضلة
  3. 3
    مؤتمر
    Minimal important difference, minimal detectable change and disease activity thresholds for two novel composite instruments, three visual analogue scale/VAS and four visual analogue scale/VAS, in patients with psoriatic arthritis: pooled analysis of three phase III studies

    المؤلفون: Tillett, William, Coates, Laura, Vis, Marijn, Merola, Joseph, Soriano, Enrique, Perate, Michelle, Shawi, May, Zimmermann, Miriam, Rampakakis, Emmanouil, Sharaf, Mohamed, Nash, Peter, Helliwell, Philip S

    مصطلحات موضوعية: Clinical sciences, Immunology, Science & Technology, Life Sciences & Biomedicine, Rheumatology

    جغرافية الموضوع: Manchester, England

    الوقت: 2023-04-24 to 2023-04-26

    العلاقة: Rheumatology; British Society for Rheumatology Annual Conference 2023 Abstracts; British Society for Rheumatology Annual Conference 2023; Tillett, W; Coates, L; Vis, M; Merola, J; Soriano, E; Perate, M; Shawi, M; Zimmermann, M; Rampakakis, E; Sharaf, M; Nash, P; Helliwell, PS, Minimal Important Difference, Minimal Detectable Change and Disease Activity Thresholds for Two Novel Composite Instruments, Three Visual Analogue Scale/vas and Four Visual Analogue Scale/vas, in Patients with Psoriatic Arthritis: Pooled Analysis of Three Phase III Studies, Rheumatology, 2023, 62; http://hdl.handle.net/10072/429940Test

    الإتاحة: https://doi.org/10.1093/rheumatology/kead104.217Test
    http://hdl.handle.net/10072/429940Test

    View record in BASE النص الكامل

    أضف إلى المفضلة
  4. 4
    مؤتمر
    LP-180 Design of a phase 2, double-blind, placebo-controlled, global trial of deucravacitinib, an oral, selective, allosteric tyrosine kinase 2 (TYK2) inhibitor, in patients with active discoid and/or subacute cutaneous lupus erythematosus

    المؤلفون: Werth, Victoria P, Merola, Joseph F, Wenzel, Joerg, Delev, Nikolay, Kothari, Harini, Meier, Richard, Singhal, Shalabh, Madireddi, Malavi, Korish, Shimon

    المصدر: E-Poster Presentation

    الإتاحة: https://doi.org/10.1136/lupus-2023-kcr.255Test

    View record in BASE

    أضف إلى المفضلة
  5. 5
    مؤتمر
    Minimal Important Difference (MID), Minimal Detectable Change (MDC), and Disease Activity Thresholds for Two Novel Composite Instruments (3VAS, 4VAS) in Patients with Psoriatic Arthritis: Pooled Analysis of Three Phase 3 Studies

    المؤلفون: Tillett, William, Coates, Laura, Vis, Marijn, Merola, Joseph, Soriano, Enrique R, Perate, Michelle, Shawi, May, Zimmermann, Miriam, Rampakakis, Emmanouil, Sharaf, Mohamed, Nash, Peter, Helliwell, Philip

    مصطلحات موضوعية: Clinical sciences, Rheumatology and arthritis, Public health, Life Sciences & Biomedicine, Rheumatology, Science & Technology

    جغرافية الموضوع: USA

    الوقت: 2022-11-10 to 2022-11-14, Philadelphia, USA

    العلاقة: Arthritis & Rheumatology; ACR Convergence 2022; Tillett, W; Coates, L; Vis, M; Merola, J; Soriano, ER; Perate, M; Shawi, M; Zimmermann, M; Rampakakis, E; Sharaf, M; Nash, P; Helliwell, P, Minimal Important Difference (MID), Minimal Detectable Change (MDC), and Disease Activity Thresholds for Two Novel Composite Instruments (3VAS, 4VAS) in Patients with Psoriatic Arthritis: Pooled Analysis of Three Phase 3 Studies, Arthritis & Rheumatology, 2022, 74 (S9), pp. 2013-2015; http://hdl.handle.net/10072/421210Test

    الإتاحة: http://hdl.handle.net/10072/421210Test

    View record in BASE النص الكامل

    أضف إلى المفضلة
  6. 6
    مؤتمر
    Effects of Treatment with Risankizumab on Minimal Disease Activity and Disease Activity in Psoriatic Arthritis: An Analysis of the KEEPsAKE-1 and -2 Trials

    المؤلفون: Merola, Joseph, McInnes, Iain B, Kavanaugh, Arthur, Nash, Peter, Xue, Zhenyi, Stakias, Vassilis, Eldred, Ann, Ciecinski, Sandra, Douglas, Kevin, Coates, Laura

    مصطلحات موضوعية: Rheumatology and arthritis, Pharmacology and pharmaceutical sciences, Clinical sciences, Public health, Life Sciences & Biomedicine, Rheumatology, Science & Technology

    جغرافية الموضوع: USA

    الوقت: 2022-11-10 to 2022-11-14, Philadelphia, USA

    العلاقة: Arthritis & Rheumatology; ACR Convergence 2022; Merola, J; McInnes, IB; Kavanaugh, A; Nash, P; Xue, Z; Stakias, V; Eldred, A; Ciecinski, S; Douglas, K; Coates, L, Effects of Treatment with Risankizumab on Minimal Disease Activity and Disease Activity in Psoriatic Arthritis: An Analysis of the KEEPsAKE-1 and -2 Trials, Arthritis & Rheumatology, 2022, 74 (S9), pp. 4211-4212; http://hdl.handle.net/10072/421203Test

    الإتاحة: http://hdl.handle.net/10072/421203Test

    View record in BASE النص الكامل

    أضف إلى المفضلة
  7. 7
    مؤتمر
    Achieving Increasingly Stringent Clinical Disease Control Criteria Is Associated with Greater Improvements in Patient-Centric Measures of Physical Function and Pain in Patients with Active PsA: 16-Week Results from Two Phase 3 Randomized, Placebo-Controlled Studies

    المؤلفون: Walsh, Jessica, Coates, Laura, Mease, Philip J, Merola, Joseph, Nash, Peter, Ogdie, Alexis, Tillett, William, Gisondi, Paolo, Ink, Barbara, Assudani, Deepak, Bajracharya, Rajan, Lambert, Jeremy, Taieb, Vanessa, Willems, Damon, Erik, Lars

    مصطلحات موضوعية: Clinical sciences, Public health, Life Sciences & Biomedicine, Rheumatology, Science & Technology

    جغرافية الموضوع: USA

    الوقت: 2022-11-10 to 2022-11-14, Philadelphia, USA

    العلاقة: Arthritis & Rheumatology; ACR Convergence 2022; Walsh, J; Coates, L; Mease, PJ; Merola, J; Nash, P; Ogdie, A; Tillett, W; Gisondi, P; Ink, B; Assudani, D; Bajracharya, R; Lambert, J; Taieb, V; Willems, D; Erik, L, Achieving Increasingly Stringent Clinical Disease Control Criteria Is Associated with Greater Improvements in Patient-Centric Measures of Physical Function and Pain in Patients with Active PsA: 16-Week Results from Two Phase 3 Randomized, Placebo-Controlled Studies, Arthritis & Rheumatology, 2022, 74 (S9), pp. 4194-4196; http://hdl.handle.net/10072/421200Test

    الإتاحة: http://hdl.handle.net/10072/421200Test

    View record in BASE النص الكامل

    أضف إلى المفضلة
  8. 8
    مؤتمر
    Efficacy of secukinumab and adalimumab in psoriatic arthritis patients with moderate-to-severe plaque psoriasis: Results from the EXCEED study

    المؤلفون: Gottlieb, Alice B, Merola, Joseph F, Reich, Kristian, Behrens, Frank, Nash, Peter, Bao, Weibin, Pellet, Pascale, Pricop, Luminita, McInnes, Iain B

    مصطلحات موضوعية: Clinical sciences, Science & Technology, Life Sciences & Biomedicine, Dermatology

    جغرافية الموضوع: San Francisco, USA

    الوقت: 2021-03-19 to 2021-03-23

    العلاقة: Journal of the American Academy of Dermatology (JAAD); American Academy of Dermatology 2021; Gottlieb, AB; Merola, JF; Reich, K; Behrens, F; Nash, P; Bao, W; Pellet, P; Pricop, L; McInnes, IB, Efficacy of secukinumab and adalimumab in psoriatic arthritis patients with moderate-to-severe plaque psoriasis: Results from the EXCEED study, Journal of the American Academy of Dermatology (JAAD), 2021, 85 (3), pp. AB92-AB92; http://hdl.handle.net/10072/414080Test

    الإتاحة: https://doi.org/10.1016/j.jaad.2021.06.388Test
    http://hdl.handle.net/10072/414080Test

    View record in BASE

    أضف إلى المفضلة
  9. 9
    مؤتمر
    Tofacitinib in patients with psoriatic arthritis: analysis of dermatologic endpoints from 2 phase 3 studies

    المؤلفون: Merola, Joseph F, Papp, Kim, Nash, Peter, Gratacos-Masmitja, Jordi, Boehncke, Wolf-Henning, Thaci, Diamant, Graham, Daniela, Hsu, Ming-Ann, Wang, Cunshan, Wu, Joseph, Young, Pamela

    مصطلحات موضوعية: Clinical sciences, Immunology, Science & Technology, Life Sciences & Biomedicine, Rheumatology

    جغرافية الموضوع: Spain

    الوقت: 2019-06-12 to 2019-06-15, Madrid, Spain

    العلاقة: Annals of the Rheumatic Diseases; Annual European Congress of Rheumatology (EULAR); Merola, JF; Papp, K; Nash, P; Gratacos-Masmitja, J; Boehncke, W-H; Thaci, D; Graham, D; Hsu, M-A; Wang, C; Wu, J; Young, P, Tofacitinib in patients with psoriatic arthritis: analysis of dermatologic endpoints from 2 phase 3 studies, Annals of the Rheumatic Diseases, 2019, 78 (Suppl 2), pp. 918-918; http://hdl.handle.net/10072/401001Test

    الإتاحة: https://doi.org/10.1136/annrheumdis-2019-eular.798Test
    http://hdl.handle.net/10072/401001Test

    View record in BASE

    أضف إلى المفضلة
  10. 10
    مؤتمر
    AB0738 DUAL NEUTRALISATION OF INTERLEUKIN (IL)–17A AND IL–17F WITH BIMEKIZUMAB IN MODERATE-TO-SEVERE PLAQUE PSORIASIS: 60-WEEK RESULTS FROM A RANDOMISED, DOUBLE-BLINDED, PHASE 2B EXTENSION STUDY

    المؤلفون: Blauvelt, Andrew, Papp, Kim a., Merola, Joseph F., Gottlieb, Alice B., Cross, Nancy, Madden, Cynthia, Wang, Maggie, Cioffi, Christopher, Griffiths, Christopher E.M.

    المصدر: Abstracts accepted for Publication

    الإتاحة: https://doi.org/10.1136/annrheumdis-2019-eular.4166Test

    View record in BASE

    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث